Skip to main content
Equibles

PANAGORA ASSET MANAGEMENT INC

Position in MGNX — Macrogenics Inc

CIK 883677 Boston, MA
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,155,711
+$621,322 QoQ
Shares Held
250,154
+35.3% QoQ
Ownership
0.393%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 122 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. MGNX ranks #47 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 175,291 $109,300,950
2 INCY
Incyte Corp
 881,889 $99,970,937
3 XENE
Xenon Pharmaceuticals Inc.
 664,031 $40,080,911
4 MIRM
Mirum Pharmaceuticals, Inc.
 337,461 $39,506,559
5 TVTX
Travere Therapeutics, Inc.
 490,724 $27,878,030
6 JAZZ
Jazz Pharmaceuticals plc
 104,935 $25,286,186
7 RLAY
Relay Therapeutics, Inc.
 1,291,182 $24,158,015
8 CLDX
Celldex Therapeutics, Inc.
 572,538 $21,304,138

All Filings in MGNX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,155,711 250,154
2026-03-31 $534,389 184,910
2025-12-31 $241,598 150,061
2025-09-30 $102,816 61,200
2024-12-31 $831,171 255,745
2024-09-30 $1,167,407 354,835
2024-06-30 $3,151,332 741,490
2024-03-31 $6,821,689 463,430
2023-12-31 $3,837,841 398,944
2023-09-30 $1,764,555 378,660
2023-06-30 $2,051,591 383,475
2023-03-31 $2,746,102 382,999
2022-12-31 $1,983,328 295,578
2022-09-30 $818,362 236,521
2022-06-30 $839,549 284,593
2022-03-31 $2,151,613 244,224
2021-12-31 $2,626,101 163,620
2021-09-30 $2,220,624 106,047
2021-06-30 $6,206,003 231,050
2021-03-31 $9,935,129 311,935
2020-12-31 $7,260,473 317,606
2020-09-30 $5,154,327 204,618
2020-06-30 $5,224,669 187,130
2020-03-31 $616,803 105,980